Publications by authors named "M E Fogaca"

Dengue is the most prevalent arboviral disease globally, with Brazil currently experiencing a significant rise in cases. Dengue virus (DENV) typically co-circulates with other clinically and antigenically similar flaviviruses, such as Zika virus (ZIKV). The clinical diagnosis is difficult and accurate serological analysis represents an unmet challenge.

View Article and Find Full Text PDF

The variola virus, the causative agent of smallpox, has claimed more human lives than all other infectious diseases combined. Consequently, any epidemiological event involving related viruses (orthopoxviruses) triggers significant concern, as was the case with the pandemic rise of monkeypox virus (MPXV), the causative agent of monkeypox in 2022-2023. Smallpox vaccines, based on vaccinia virus antigens, are expected to provide cross-protection against MPXV.

View Article and Find Full Text PDF
Article Synopsis
  • Major depressive disorder (MDD) disrupts glutamate and GABA activity in the medial prefrontal cortex (mPFC), affecting synaptic function, but low doses of ketamine can quickly reverse these issues and provide lasting antidepressant effects.
  • Research shows that ketamine first decreases GABA neuron activity before increasing it over time, along with enhancing glutamatergic signaling, indicating a complex relationship influencing its sustained effects.
  • Inhibition of GABA interneurons during the increased activity phase blocks ketamine's antidepressant impact, highlighting the importance of timing in GABAergic modulation as a potential target for new antidepressant treatments.
View Article and Find Full Text PDF

Three lateral flow immunoassay prototypes developed to detect IgM, IgG and IgM/IgG antibodies against Hantavirus were evaluated. A total of 163 samples were tested: 10 from Hantavirus patients, 103 from related diseases, and 50 from healthy controls. The prototypes exhibited 100 % sensitivity, 97.

View Article and Find Full Text PDF

Major depressive disorder (MDD) is associated with disruptions in glutamatergic and GABAergic activity in the medial prefrontal cortex (mPFC), leading to altered synaptic formation and function. Low doses of ketamine rapidly rescue these deficits, inducing fast and sustained antidepressant effects. While it is suggested that ketamine produces a rapid glutamatergic enhancement in the mPFC, the temporal dynamics and the involvement of GABA interneurons in its sustained effects remain unclear.

View Article and Find Full Text PDF